139 related articles for article (PubMed ID: 7829272)
21. Transmission of human T-cell leukaemia virus type I into adult mice.
Ohsugi T
Lab Anim; 2000 Oct; 34(4):439-45. PubMed ID: 11072867
[TBL] [Abstract][Full Text] [Related]
22. Human T lymphotropic virus types I- and II-specific antibody-dependent cellular cytotoxicity: strain specificity and epitope mapping.
Zhang XQ; Yang L; Ho DD; Kuritzkes DR; Chen IS; Ching WT; Chen YM; Schooley RT
J Infect Dis; 1992 May; 165(5):805-12. PubMed ID: 1373751
[TBL] [Abstract][Full Text] [Related]
23. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
[TBL] [Abstract][Full Text] [Related]
24. Comparative biological responses of rabbits infected with human T-lymphotropic virus type I isolates from patients with lymphoproliferative and neurodegenerative disease.
Lairmore MD; Roberts B; Frank D; Rovnak J; Weiser MG; Cockerell GL
Int J Cancer; 1992 Jan; 50(1):124-30. PubMed ID: 1345820
[TBL] [Abstract][Full Text] [Related]
25. Effect of immunization on HTLV-I infection in rabbits.
Takehara N; Iwahara Y; Uemura Y; Sawada T; Ohtsuki Y; Iwai H; Hoshino H; Miyoshi I
Int J Cancer; 1989 Aug; 44(2):332-6. PubMed ID: 2759739
[TBL] [Abstract][Full Text] [Related]
26. Intracellular processing and immunogenicity of the envelope proteins of human T-cell leukemia virus type I that are expressed from recombinant vaccinia viruses.
Seki M; Sashiyama H; Hayami M; Shida H
Virus Genes; 1990 Feb; 3(3):235-49. PubMed ID: 2189258
[TBL] [Abstract][Full Text] [Related]
27. Immunization with a vaccinia recombinant expressing the F protein protects rabbits from challenge with a lethal dose of rinderpest virus.
Barrett T; Belsham GJ; Subbarao SM; Evans SA
Virology; 1989 May; 170(1):11-8. PubMed ID: 2718375
[TBL] [Abstract][Full Text] [Related]
28. Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits.
Kataoka R; Takehara N; Iwahara Y; Sawada T; Ohtsuki Y; Dawei Y; Hoshino H; Miyoshi I
Blood; 1990 Oct; 76(8):1657-61. PubMed ID: 1976391
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of an HTLV-1 subunit vaccine in prevention of a STLV-1 infection in pig-tailed macaques.
Dezzutti CS; Frazier DE; Olsen RG
Dev Biol Stand; 1990; 72():287-96. PubMed ID: 2178125
[TBL] [Abstract][Full Text] [Related]
30. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.
Hiraragi H; Kim SJ; Phipps AJ; Silic-Benussi M; Ciminale V; Ratner L; Green PL; Lairmore MD
J Virol; 2006 Apr; 80(7):3469-76. PubMed ID: 16537614
[TBL] [Abstract][Full Text] [Related]
31. Protracted Treponema pallidum-induced cutaneous chancres in rabbits infected with human T-cell leukemia virus type I.
Tseng CT; Sell S
AIDS Res Hum Retroviruses; 1991 Mar; 7(3):323-31. PubMed ID: 2064829
[TBL] [Abstract][Full Text] [Related]
32. Evidence for dual infection of rabbits with the human retroviruses HTLV-I and HIV-1.
Truckenmiller ME; Kulaga H; Gugel E; Dickerson D; Kindt TJ
Res Immunol; 1989; 140(5-6):527-44. PubMed ID: 2781136
[TBL] [Abstract][Full Text] [Related]
33. Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies.
Tallet B; Astier-Gin T; Moynet D; Londos-Gagliardi D; Guillemain B
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):337-48. PubMed ID: 11242520
[TBL] [Abstract][Full Text] [Related]
34. Functional conservation of the neutralizing domains on the external envelope glycoprotein of cosmopolitan and melanesian strains of human T cell leukemia/lymphoma virus type I.
Hoshino H; Nakamura T; Tanaka Y; Miyoshi I; Yanagihara R
J Infect Dis; 1993 Dec; 168(6):1368-73. PubMed ID: 7504032
[TBL] [Abstract][Full Text] [Related]
35. Transmission of human T cell leukemia virus type I to sheep: antibody profile and detection of viral DNA sequences.
Esteban EN; Sherman MP; Poiesz BL; Marshak RR; Waters DJ; Ferrer JF
AIDS Res Hum Retroviruses; 1996 Dec; 12(18):1717-24. PubMed ID: 8959249
[TBL] [Abstract][Full Text] [Related]
36. Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
Tezuka K; Okuma K; Kuramitsu M; Matsuoka S; Tanaka R; Tanaka Y; Hamaguchi I
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212930
[TBL] [Abstract][Full Text] [Related]
37. Immunoglobulin prophylaxis against human T cell lymphotropic virus type II in rabbits.
Morishita N; Ishii K; Tanaka Y; Sawada T; Hoshino H; Foung SK; Miyoshi I
J Infect Dis; 1994 Mar; 169(3):620-3. PubMed ID: 8158037
[TBL] [Abstract][Full Text] [Related]
38. Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.
Desgranges C; Souche S; Vernant JC; Smadja D; Vahlne A; Horal P
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):163-73. PubMed ID: 8198868
[TBL] [Abstract][Full Text] [Related]
39. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.
Rouet F; Meertens L; Courouble G; Herrmann-Storck C; Pabingui R; Chancerel B; Abid A; Strobel M; Mauclere P; Gessain A
J Clin Microbiol; 2001 Apr; 39(4):1247-53. PubMed ID: 11283036
[TBL] [Abstract][Full Text] [Related]
40. Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.
Tanaka Y; Tanaka R; Terada E; Koyanagi Y; Miyano-Kurosaki N; Yamamoto N; Baba E; Nakamura M; Shida H
J Virol; 1994 Oct; 68(10):6323-31. PubMed ID: 8083972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
